Illaterials
A total of 17 patients with hepatic cirrhosis diagnosed by the usual clinical and laboratory criteria were selected from the wards and clinics of the King County Hospital, Seattle. Eleven patients of comparable age, lacking cirrhosis or other diseases known to affect cerebral metabolism, served as "normal" controls. Four noncirrhotic patients with old clinically-stable brain lesionls (one with focal brain infarction, two with diffuse, moderate cerebral arteriosclerosis, and one with posthypoglycemic brain damage.) served as controls for studying the effect of CO, inhalation on cerebral metabolism. One of these subjects and four additional subjects with cerebral arteriosclerosis served as controls when the effects of acetazolamide on hepatic encephalopathy wvere studied. All patients and controls received careful mental and neurological examinations. The degree of encephalopathy in the cirrhotics was graded from 0 to 4 usinig the following criteria.
(Grade 0. The patients were fully alert anid Qriented. They had intact recent memory and performed serial sevens or serial threes correctly and easily. The somatic neurological examination was normal. The respiratory rate and depth appeared normal. Grade 1. The patients were fully alert and oriented. Although recent memory was good, mental testing uncovered errors, e.g., date of admission to hospital. Serial sevens were mildly impaired. The somatic neurological examination was normal. The respiratory rate and depth appeared normal. Since presumably normal persons from a similar age group and socioeconomic background frequenltly show this minimal impairment, Grade 1 was considered uncertaiin evidence for encephalopathy and was clinically classified with Grade 0 for metabolic analysis.
Gradc 2. The patients were lethargic and mildly confused. They usually were oriented correctly to person and place but incorrectly to time. Serial sevens were performed poorly. Most patients had arrhythmic lateral twitching of the extended fingers and some had the classic "metabolic flap" described by Adams and Foley (15) . The respiratory rate and depth appeared normal.
Grade 3. The patients were frankly confused and intermittently somnolent. Disorientation was usually complete so that appropriate conversation was impossible. The somatic neurological examination often elicited hy-1246 peractive deep tendon reflexes, paratonic rigidity and extensor plantar responses. A metabolic flap was invariably present.
Grade 4. The patients were comatose and responded only to vigorous painful stimuli. They were obviously hyperventilating.
Procedure
All patients were taken to the laboratory in the early morning before breakfast. A mental and somatic neurological examination was performed. Following this, no. 18 needles were inserted into the femoral artery and jugular bulb (16) , and a snugly fitting face mask was applied. The blood pressure and alveolar CO2 tension (PAco2) were monitored. The patients rested for 20 minutes or more while respiratory exchange and blood pressure stabilized. Cerebral blood flow using 15 per cent N20, 21 per cent 02, and 64 per cent N2 was then determined. During the determination each patient was observed repeatedly for variations in muscular tremor and resistance. At the end of this first procedure, all patients rested 10 to 15 minutes. Following this rest period, the effects of inhaled CO2 or infused acetazolamide were then studied in selected subjects.
To determine the effects of inhaled CO., subjects were placed on 5 per cent CO. in air for approximately 20 minutes to develop a stable response to the gas. After this adaptation, the gas mixture was switched to 15 per cent N.0, 5 per cent C02, 21 per cent 02 and 59 per cent N2, and the cerebral blood flow was repeated, muscular tremor and resistance being watched closely throughout. Detailed mental and neurological testing was repeated as soon as CO2 breathing terminated.
To determine the effects of acetazolamide, 0.5 to 2 g of the drug was infused intravenously, several minutes being allowed for administration. Thirty minutes later the cerebral blood flow determination was repeated, with the mental and somatic neurological examination being repeated at the end of this second procedure.
llethods
The cerebral blood flow was determined by Scheinberg and Stead's modification (17) of Kety and Schmidt's original method (18) . Slight variations improved the technique's accuracy (19) . The 10-minute samples were machine-drawn at a constant rate to assure more accurate integration. Calculations (17) included arithmetical correction for dead space between vessel and syringe (19) .
Blood was collected in heparin-washed syringes, immediately capped and mercury-sealed. Care was taken to avoid air bubbles. Immediately after drawing, the blood pH was determined at 370 C with a Beckman microelectrode attached to a Cambridge model R pH meter. Each sample was repeatedly measured until duplicate agreement of 0.01 pH unit was achieved. The duplicate blood oxygen and carbon dioxide contents were measured manometrically by Peters and Van Slyke's method (20) , and the arterial carbon dioxide tension (Paco2) was determined on the Singer and Hastings nomogram (21). Oxygen tension was estimated from the Dill nomogram, using Severinghaus' correction factors for pH (22) . The blood nitrous oxide was measured by Kety and Schmidt's method (18) , each sample being repeated until duplicate agreement of 0.02 volume per cent was achieved. The blood ammonia was determined by Seligson and Hirahara's method (23) and the mean of the two closest of three determinations was the figure chosen.
The arterial blood pressure was recorded directly from the femoral artery through a Statham transducer and a Sanborn strain gage amplifier. The expired carbon dioxide was monitored by an infrared analyzer (Liston-Becker), gas samples being drawn continuously through a needle in the patient's mask. Figure 1 show the arterial pH levels from cirrhotic patients in Grades 0 to 4. There was overlapping between individual pH values accompanying different grades of encephalopathy although patients with moderate and severe encephalopathy had higher mean pH determinations than did patients graded 0 to 2. All but one of the patients without encephalopathy were alkalotic (mean pH 7.48), although clinically evident hyperventilation was absent. Most Grade 3 patients had higher arterial blood Cerebral oxygen uiptake. Table I and Figure 1 show CMRo, values from cirrhotic patients. A-VO2 differences were mildly increased but not sufficiently to compensate for the strikingly reduced blood flow, and CMRo2 was decreased below 2.0 cc per 100 g per minute (mean 1.6 cc) in each determination.
RESULTS

Normal values
Effect of carbon dioxide inhalation Clinical response. One cirrhotic and four Grade 0 patients and four noncirrhotic subjects with static brain lesions showed no mental or neurological alterations after inhaling 5 per cent CO2 for 30 minutes. By contrast, five of the eight cirrhotic patients (one patient was studied twice) with encephalopathy became clinically worse during and shortly after inhaling 5 per cent CO2. They showed increased confusion, disorientation and dysarthria, as well as intensified amplitude and frequency of muscular tremor. The mental and neurological deterioration was transient (30 to 120 minutes) in four, but the fifth (L.J.) progressed into coma and died 72 hours later. Paradoxically, L.J. was the only one of the five patients whose clinical deterioration during the second blood flow determination was unaccompanied by a reduced cerebral oxygen uptake.
Metabolic effects. Since the response of cirrhotics without encephalopathy to CO2 inhalation was similar to that of the controls, data in these groups are summarized together in Table II.  Table III lists the cerebral metabolic responses of patients with hepatic encephalopathy. Figure 2 compares the CMR02 responses in the two groups.
The arterial pH fell and the Paco2 rose in every patient during CO2 inhalation. These pH and PacO2 changes were greater when the patient had encephalopathy, indicating a lesser ventilatory response to CO2. Carbon dioxide inhalation evoked a 33 per cent mean CBF increase among noncirrhotic controls and a 46 per cent mean CBF increase among cirrhotics. Each group had several subjects in whom CBF did not increase significantly. These changes are considerably lower than are normal responses of the cerebral circulation to increased CO2 (18) and were to be expected among the controls, three of whom were selected because of arteriosclerotic brain damage. The diminished circtulatory response of cirrhotics was unexpected, but may, in part, also be explained by arteriosclerosis, since their mean age was 56 years. In any case, the mean CBF response was roughly comparable be- Cerebral oxygen uptake. Table IV presents the metabolic changes which followed acetazolamide injection in controls, and Table V presents these changes in subjects with hepatic encephalopathy. Figure 3 compares the CMRo2 responses between the two groups.. Every subject, both control and cirrhotic, exhibited an arterial pH fall after acetazolamide. Five hundred mg, or 1 g dosages evoked no blood pressure response, but when 2 g acetazolamide was administered, both control and cirrhotic subjects consistently developed a blood pressure rise (mean 20 mm Hg). Every patient, whether a control or cirrhotic, increased his cerebral blood flow considerably when given either 1 or 2 g acetazolamide. The cerebral oxygen uptake (CMRo2) of control subjects showed no significant (p = > 0.8) mean change following acetazolamide in either 1 or 2 g amounts. Similarly, the cerebral oxygen uptake of patients with hepatic encephalopathy was unaltered when only 0.5 or 1 g of acetazolamide was given. However, when the infused acetazolamide dosage was raised to 2 g (the dose required to raise blood pressure), every patient with hepatic encephalopathy showed a significant (p = < 0.02 > 0.01) CMRO2 drop, the smallest decline being 0.5 cc per 100 g per minute.
Cerebral ammonia uptake. Four controls and all of the subjects with hepatic encephalopathy had arterial and venous ammonia levels measured wh-llile acetazolamilide effects (Tables IV and V) were l)ein-g (leteriiiined. Neitlher the arterial blood amminloinia lexel nior tile cerebral atimomia u)take showe(l any changes correlating witlh the clinical or metabolic response to acetazolamide. Thus, arterial ammonias either decreased or stayed the same while cerebral ammonia uptake (CMRNHI) increased in some subjects and decreased in others. DISCUSSION Correlation of cerebral mietabolismii and encephalopathy. Our data are consistent with those of Kety (24) and Lassen (25) mentally alert cirrhotic patients show depressed oxygen consumptions with a mean of 2.3 cc per 100 g per minute. Unless they included Group 2 patients among those classified as "alert" (26) , no explanation for Fazekas' unique experience is forthcoming. Although our Group 4 sample is small, our data also fail to confirm Fazekas' finding that comatose patients showed a CMRO2 no lower than still-conscious subjects.
Relationship of encephalopathy, arterial blood pH and respiratory gases. Respiratory alkalosis is one of the most consistent biochemical accompaniments of severe liver disease and few of the present subjects lacked this change, whether or not they showed neurological impairment. Vanamee and associates (1) reported that 25 out of 29 patients with hepatic encephalopathy were alkalotic, and others (4, 27) have observed similar findings. If frankly acidotic patients (those with renal failure) are omitted from the data of the Vanamee group, the mean blood pH rose progressively as encephalopathy increased. Tyor and Sieker (4), although confirming the nearubiquity of arterial blood alkalosis, noted less correlation between the absolute pH level and the degree of encephalopathy. However, Tyor and Sieker did find in individual cases that the arterial pH rose as encephalopathy progressed. Robin, Whaley, Crump and Travis (27) noted no correlation between arterial hypocapnia and state of consciousness. Our own data correspond more with Vanamee's, since the mean arterial blood pH rose as encephalopathy progressed from Grade 0 to Grade 4. Despite the pH rise, hyperventilation was evident clinically only when neurological changes were pronounced (Grades 3, 4).
Arterial Paco2 levels were depressed commensurately with the degree of alkalosis, being lowest among comatose subjects. Alkalosis and hypocapnia reduce cerebral blood flow (10) and impair alertness and equilibrium in the hyperventilation syndrome (28) . Reduction of Paco2 comparable with that seen in hepatic encephalopathy produces electroencephalographic (EEG) abnormalities in animals (29) , indicating cerebral dysfunction. Despite the evidence that hypocapnia sometimes is deleterious, it seems doubtful that low blood carbon dioxide levels contribute importantly to hepatic encephalopathy. Hyperventilation during routine adult human EEG recordings seldom produces marked slowing unless epilepsy or hypoglycemia (30) is present. Some cirrhotic patients with intact mentation and cerebral metabolism show just as much hypocapnia as do others in coma (Table I) (1, 4) . Hyperventilation alkalosis comparable with that of liver disease failed to depress cerebral metabolism in Kety and Schmidt's normal subjects (10) . Finally, reversing hypocapnia with CO2 therapy in the present study failed to ameliorate either the clinical or the metabolic manifestations of encephalopathy.
The arterial oxygen desaturation which accompanies all grades of hepatic encephalopathy (Table  I) is usually modest. However, because of the respiratory alkalosis of advanced cirrhosis, the resultant Pao2 is considerably lower at any given oxygen saturation than would be the case if pH were normal (9) . As a result, several cirrhotics in the present study showed alarmingly low Pao2 values. Although this depression of available oxygen may be an unfavorable influence in hepatic encephalopathy, it is an unlikely cause for the condition, since no correlation was observed by either ourselves or others (4) between mean Pao2 and depth of coma. The low values do suggest that oxygen therapy might be a useful adjunct to treating seriously ill patients with liver disease.
The mechanism of alkalosis in liver disease. The alkalosis of severe liver disease is clearly due to relative overbreathing, although the hyperventilation usually remains moderate and clinically unapparent until severe encephalopathy develops. The moderate anoxemia which often accompanies cirrhosis (4, 31, 32) is insufficient to account for the hyperpnea (33) . Peripheral reflexes from the lungs stimulating the respiration (34) have not been examined. Lacking evidence for other mechanisms, most workers who have studied the problem (11, 32, 35) speculate that the hyperventilation of cirrhosis arises centrally, presumably from biochemical stimulation of respiratory center neurons.
Examples of central hyperventilation in other diseases exist, although the respiratory changes are rare in the absence of other manifestations of neurological impairment. Thus, when hyperpnea develops in metabolic acidosis, consciousness is usu-ally impaired. Similarly, the hyperventilation which is seen with medial pontine tegnmental lesions in man is accompanied by profound neurological dysfunction in nonrespiratory spheres (36) . The clinical picture of severe metabolic encephalopathy with comia, muscular rigidity, fixed extraocular movements and sustained evident hyperpnea closely resembles the signs and symptoms which follow medial pontine infarction. However, hyperpnea is seen in patients with liver cirrhosis long before any other sign of presumed neurological dysfunction. This suggests that either brain stem respiratory-controlling neurons have an extraordinary susceptibility to the metabolic dysfunction of liver disease or that peripheral stimulating mechanisms need closer study than they have heretofore received.
If hyperventilation in liver disease does have a central origin, the biochemical process that either stimulates facilitatory neurons or blocks normally inhibitory respiratory nerve cells is presently unknown. Roberts, Thompson, Poppell and Vanamee (11), Sherlock (35) and others have considered raised blood ammonia to cause hyperventilation, pre umably by directly stimulating the respiratory centers. Evidence to support this supposition is conflicting. There are reports that hyperventilation follows ammiionia infusions in dogs (11), mice (14) and men (37) . However, another carefuly controlled and detailed human experiment (38) showed no significant arterial blood pH change during ammonia infusions that produced arterial blood ammonia levels exceeding 500 ug per 100 ml. Ammonium salts infused directly into dogs' carotid arteries produced only slight and transient arterial blood pH elevations (39) . These observations plus the lack of correlation between arterial blood ammonia, and either pH (4) (14, 43) , and this alone should lessen the brain uptake.) Also, the deterioration could not be attributed to deleterious effects resulting from the muscular efforts of CO.,-induced hyperpnea, since sinmilar deterioration without hyperpnea followed increasing tissue CO, tensions with acetazolamide.
Carbon dioxide is a toxic gas, although concentrations higher than those employed here usually are required for toxic effect. Inhaling 10 per cent CO2 can make normal persons comatose (44) (38) . How carbon dioxide specificially affects nerve cell metabolism is unknown, although the gas alters the function of central neurons extending far beyond the respiratory centers (29) . If the speculation that accumulating intracellular acid metabolites cause hepatic encephalopathy proved to be true, this would readily explain why carbon dioxide is toxic. The diffusibility of CO., across membranes rapidly makes the cerebral spinal fluid (45) and, presumably, brain cells more acidic. Other acid radicals have no such prompt effect (46) . Thus, carbon dioxide would particularly intensify the already existing biochemical disturbance. In any case, there is little present evidence that respiratory alkalosis harms cirrhotics, and it is apparent that using carbon dioxide to reverse the alkalosis increases the encephalopathy.
The mechanism of acetazolamide toxicity. Clinical and cerebral metabolic deterioration was prompt and striking in the patients with hepatic encephalopathy who received 2 g of intravenous acetazolamide. Indeed, the response was such that we felt unjustified in extending the study to a larger group of cirrhotics.
Acetazolamide is not an inherently toxic drug. Normal subjects sometimes develop drowsiness and paresthesias after receiving doses of the drug exceeding 1 g (47) (48) (49) , and such a response was observed to begin about 2 hours after infusion in one of our controls. This response, whose mechanism is unknown, was qualitatively entirely different from the increased confusion and mental obtundity found in the cirrhotics, and the time -delay was also dissimilar to the cirrhotics' immediate worsening.
The toxic effects of acetazolamide in hepatic encephalopathy described here appear to be best explained as resulting directly from increased cerebral CO, tensions. Several things suggest this conclusion.
1. Acetazolamide's only known direct metabolic effect is carbonic anhydrase inhibition (50) . which increases venous and tissue PcO2 (51 2. Alert cirrhotic patients had respiratory alkalosis and the degree of alkalosis increased progressively as encephalopathy appeared and worsened.
3. The cerebral oxygen uptake was normal in alert cirrhotics, but the uptake progressively de-creased as hepatic encephalopathy developed and worsened.
4. Five per cent carbon dioxide produced no adverse effects on alert cirrhotics or patients with static brain disease. However, inhaling 5 per cent CO2 caused both clinical deterioration and significantly decreased cerebral oxygen uptake in patients having hepatic encephalopathy. The arterial blood ammonia decreased and the cerebral ammonia uptake declined during CO2 inhalation.
5. Acetazolamide infusions produced no significant clinical or cerebral metabolic rate (CMR) changes in control subjects. Patients with hepatic encephalopathy showed no CMRo2 change when given 0.5 or 1 g of the drug. However, when patients with hepatic encephalopathy received 2 g of acetazolamide, they promptly deteriorated clinically and significantly decreased their cerebral oxygen consumption. The arterial ammonia level did not increase in any instance.
6. This study suggests that the toxicity of acetazolamide in hepatic encephalopathy directly results from increased cerebral tissue carbon dioxide tensions. It is postulated that respiratory alkalosis in advanced liver disease is compensatory, acting to protect rather than to impair brain function. 
